GSK in talks to acquire Nuvalent for more than $9 billion in biggest deal in over a decade: FT
--------------------------------------------------------------------
Source: CNBC
Published: 2026-06-09 14:31 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Europe, Economy & Finance, Business & Economy
--------------------------------------------------------------------
Snippet:
UK pharmaceutical group GSK is in talks to acquire oncology biotech Nuvalent for more than $9 billion, in what would be the British drugmaker's largest acquisition in more than a decade, the Financial Times reported Tuesday.
--------------------------------------------------------------------